Volodymyr Nazarko

Volodymyr Nazarko, Ph.D., is a Principal Quality Control Analyst at Curia since January 2022, previously serving as a Senior Research Scientist II in Research Analytics. Nazarko has extensive experience in project execution, client communication, and scientific analysis, having worked at LakePharma, Inc. as a Senior Scientist I focusing on Pharma Assays and Analytics. Prior to that, Nazarko contributed to research at WELGEN, INC. as a Research Scientist and held postdoctoral research positions at the University of Illinois at Chicago and the University of Texas Southwestern Medical Center, specializing in autophagy in yeast and cancer cell lines, respectively. Trained in Next Generation Sequencing (NGS), Nazarko's work spans various aspects of biological research and analytics.